Adjuvant Therapy in the Treatment of Melanoma

Adjuvant Therapy in the Treatment of Melanoma Ann Surg Oncol (2018) 25:1807–1813 https://doi.org/10.1245/s10434-018-6376-y CO NTINU I NG EDU C A T IO N– MELA NO MA S Danielle M. Bello, MD and Charlotte E. Ariyan, MD, PhD Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY INTRODUCTION the adjuvant treatment; (3) personal and financial cost; and (4) salvage options that exist. Melanoma is an aggressive form of cutaneous malig- In melanoma, the risk of recurrence is usually estimated nancy, with over 10,000 deaths in the US in 2016. In the after the initial staging operation, which identifies the past 10 years, treatment for stage IV disease with targeted important prognostic clinical and pathologic factors. therapy and immune therapy has changed the trajectory of Online calculators are available to help estimate risk over the disease. While the median survival of patients with time, including melanomacalculator.com, cancermath.net stage IV disease was historically \ 1 year, there are now (which was developed by the Laboratory of Quantitative patients alive without disease recurrence for more than Medicine of Massachusetts General Hospital), or 10 years. The successful treatment of stage IV patients melanomaprognosis.net (which was developed by the raises the question as to whether patients with high-risk American Joint http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Annals of Surgical Oncology Springer Journals

Adjuvant Therapy in the Treatment of Melanoma

Loading next page...
 
/lp/springer_journal/adjuvant-therapy-in-the-treatment-of-melanoma-Ds4BKcoxCZ
Publisher
Springer International Publishing
Copyright
Copyright © 2018 by Society of Surgical Oncology
Subject
Medicine & Public Health; Surgical Oncology; Oncology; Surgery
ISSN
1068-9265
eISSN
1534-4681
D.O.I.
10.1245/s10434-018-6376-y
Publisher site
See Article on Publisher Site

Abstract

Ann Surg Oncol (2018) 25:1807–1813 https://doi.org/10.1245/s10434-018-6376-y CO NTINU I NG EDU C A T IO N– MELA NO MA S Danielle M. Bello, MD and Charlotte E. Ariyan, MD, PhD Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY INTRODUCTION the adjuvant treatment; (3) personal and financial cost; and (4) salvage options that exist. Melanoma is an aggressive form of cutaneous malig- In melanoma, the risk of recurrence is usually estimated nancy, with over 10,000 deaths in the US in 2016. In the after the initial staging operation, which identifies the past 10 years, treatment for stage IV disease with targeted important prognostic clinical and pathologic factors. therapy and immune therapy has changed the trajectory of Online calculators are available to help estimate risk over the disease. While the median survival of patients with time, including melanomacalculator.com, cancermath.net stage IV disease was historically \ 1 year, there are now (which was developed by the Laboratory of Quantitative patients alive without disease recurrence for more than Medicine of Massachusetts General Hospital), or 10 years. The successful treatment of stage IV patients melanomaprognosis.net (which was developed by the raises the question as to whether patients with high-risk American Joint

Journal

Annals of Surgical OncologySpringer Journals

Published: Feb 21, 2018

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off